Skip to content
PICO Portalanswers from OpenAlex

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation

PaperCitations, authors & open-access status

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is a paper indexed in PICO Portal from OpenAlex.

How many citations does A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation have?

PICO Portalcitation count

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation has 184 citations in the OpenAlex counts PICO Portal stores.

When was A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation published?

PICO Portalyear

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation has 2007 year in the PICO Portal index.

What is the open-access status of A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

PICO Portaloa status

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation has hybrid oa status in the PICO Portal index.

What is the DOI of A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

PICO Portaldoi

The DOI for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is on the source record.

What is the PMID of A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

PICO Portalpmid

The PMID for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is on the source record.

What is the OpenAlex record for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation?

PICO Portalopenalex

The OpenAlex for A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial